Karin Wingstrand
R&D
Adenovir Pharma
Sweden
Biography
Extensive senior experience of pharmaceutical research and development. Most recently as Global Head and Vice President Clinical Development within AstraZeneca and before that as Global Head and Vice President Pharmaceutical and Analytical R&D, AstraZeneca. Presently Advisor within Life Science and Board member of T-bolaget AB and Sahlgrenska Forskningsstiftelsen. PULS Partner and board member of PULS AB.
Research Interest
Pharmaceutical research and development